Anthem Biosciences announces earnings conference call for audited Q4 and FY2026 results on May 20, 2026.
Call will feature MD & CEO Ajay Bhardwaj and CFO Gawir Baig, hosted by JM Financial.
Disclosure made under SEBI Listing Regulations (Regulation 30) for compliance purposes.
Universal dial-in numbers provided for international participants across multiple time zones.